Page last updated: 2024-10-23

berberine and Parkinsonian Disorders

berberine has been researched along with Parkinsonian Disorders in 3 studies

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
"The effects of berberine on long-term administration of L-DOPA in 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease (PD) were investigated."1.39Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. ( Choi, HS; Choi, SO; Kwon, IH; Lee, MK; Shin, KS; Suh, KH; Zhao, TT, 2013)
" It is, therefore, suggested that the use of long-term l-DOPA therapy with isoquinoline derivatives including berberine may need to be examined for the presence of adverse symptoms."1.36Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease. ( Choi, HS; Hwang, BY; Kwon, IH; Lee, BK; Lee, CK; Lee, MK; Lim, SC; Shin, KS, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, KS2
Choi, HS2
Zhao, TT1
Suh, KH1
Kwon, IH2
Choi, SO1
Lee, MK2
Mo, J1
Zhang, H1
Yu, LP1
Sun, PH1
Jin, GZ1
Zhen, X1
Lee, BK1
Lee, CK1
Hwang, BY1
Lim, SC1

Other Studies

3 other studies available for berberine and Parkinsonian Disorders

ArticleYear
Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Archives of pharmacal research, 2013, Volume: 36, Issue:6

    Topics: Animals; Antiparkinson Agents; Berberine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy,

2013
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Neurobiology of aging, 2010, Volume: 31, Issue:6

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsy

2010
Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
    Neuroscience letters, 2010, Dec-03, Volume: 486, Issue:1

    Topics: Animals; Berberine; Cell Death; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Rel

2010